![]() ![]() PharmaSens AG, a privately owned Swiss company dedicated to expanding access to insulin pump therapy, today announced the successful and timely submission of its application for FDA approval for the revolutionary "niia essential" insulin pump system. ![]() ![]() Engaging in strategic financial discussions, PharmaSens prepares for a dynamic market entry and continuous development in diabetes care technologyīiel/Bienne (Switzerland), December 29, 2023.'niia essential' Insulin Patch Pump System targets the significant yet underserved 'almost pumpers' market, tapping into an estimated $10 billion opportunity.FDA application for the 'niia essential' marks a major milestone in advancing insulin pump technology with its innovative, patient-centric design.PharmaSens Successfully Submits FDA Approval Application for Groundbreaking Insulin Pump System ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |